Blueprint Medicines Corp. (2L9)
Market Open
28 Jul, 07:56
XFRA 
NASDAQ (NGS) Primary XFRA €
2. 20
-0.25
-10.2041%
€
- Market Cap
- P/E Ratio
- Div Yield
50 Volume
-8.6 Eps
€ 2.45
Previous Close Want to track 2L9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Blueprint Medicines Corp. Price History
No Data
